News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Daily News ‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD Todd Neale June 27, 2024
News Daily News Injectable Semaglutide Shortage Forces Physicians to Pivot Todd Neale February 05, 2024
News Conference News AHA 2023 Simultaneous Dual Cardioversion of AF Lessens Failure Rates in Obese Patients Todd Neale November 14, 2023
News Daily News Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle Todd Neale September 12, 2023
News Daily News EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss Michael O'Riordan July 12, 2023
News Daily News Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death Michael O'Riordan July 07, 2023
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT Michael O'Riordan November 06, 2022
News Daily News Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors Michael O'Riordan June 16, 2021
News Daily News Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds Michael O'Riordan February 06, 2020
News Daily News Weight Training, Aerobic Exercise Affect Cardiac Fat Mass in Different Ways Michael O'Riordan July 05, 2019
News Conference News ACC 2019 New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead Michael O'Riordan March 17, 2019
News Daily News Obesity Not Benign: Higher Risk of CVD Seen With Excess Weight Michael O'Riordan June 05, 2018
News Daily News Roughly Half of Obese Patients Who Have Bariatric Surgery Are Off Type 2 Diabetes Meds at 6 Years Michael O'Riordan February 19, 2018
News Daily News Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors Michael O'Riordan December 12, 2017
News Daily News Diabetes Remission Possible With Significant Weight Loss: DiRECT Michael O'Riordan December 05, 2017
News Daily News Weight Loss May Affect Diabetes Risk, but Not Future CVD Outlook L.A. McKeown August 04, 2016
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016